company

FARMATEK SKANDINAVIA AS

1940 BJØRKELANGEN

Return on Equity
36,41 %
Current Ratio
2,69
Debt-to-Equity Ratio
2,65
Key figures (NOK)2022
Revenue3 902 000
Net Income150 000
Total Assets2 389 000
Total Equity412 000
Income (NOK)2022
Revenue3 902 000
Expenditure4 236 000
Operating Profit144 000
Financial Income14 000
Financial Costs9 000
Financial Balance5 000
Earnings Before Tax150 000
Tax0
Net Income150 000
Balance (NOK)2022
Total Fixed Assets3 000
Total Current Assets2 385 000
Total Assets2 389 000
Total Retained Equity62 000
Total Equity412 000
Total Long-Term Debt1 090 000
Total Current Debt886 000
Total Equity and Debt2 389 000
Cash flow (NOK)2022
Sales Income3 902 000
Other Income0
Revenue3 902 000
Cost of Goods Sold2 249 000
Salary Costs867 000
Depreciation33 000
Impairment0
Expenditure4 236 000
Operating Profit144 000
Financial Income14 000
Financial Costs9 000
Financial Balance5 000
Dividends0
Net Income150 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures3 000
Total Tangible Assets3 000
Total Fiancial Fixed Assets0
Total Fixed Assets3 000
Stock1 776 000
Total Investments0
Cash, Bank150 000
Total Current Assets2 385 000
Total Assets2 389 000
Total Equity412 000
Short-Term Group Debt0
Total Long-Term Debt1 090 000
Creditors627 000
Unpaid Taxes109 000
Dividends0
Other Current Debt150 000
Total Current Debt886 000
Total Equity and Debt2 389 000
Financial indicators2022
Return on Equity36,41 %
Debt-to-Equity Ratio2,65
Operating Profit Margin3,69 %
Current Ratio2,69
Quick Ratio−2,68
Equity Ratio0,17
Gross Profit Margin42,36 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English